0 a condition in which a body is unable to produce enough antibodies to fight bacteria and viruses, often resulting in infection and disease
Nevertheless, these immunodeficiencies, whatever their type and severity, are not the only triggering mechanism.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
Promising results have been observed in treatment of cancer and cardiovascular diseases and, most recently, in inherited severe combined immunodeficiency and hemophilia.
The association of this infection with immunodeficiency and its pathogenicity for patients need to be investigated further.
Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries.
Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.
The exact mechanisms by which malignant disseminated strongyloidiases are caused during various types of immunodeficiencies are not well understood.
Increased occurrence in severe combined immunodeficiency and other hematopoietic diseases.
